TRCT
OCGN icon

Tower Research Capital (TRC)’s Ocugen OCGN Stock Holding History

Tower Research Capital (TRC)’s Portfolio OCGN Stock Details OCGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.4K Sell
20,543
-531
-3% -$807 ﹤0.01% 3139
2026
Q1 		$38.1K Sell
21,074
-40,699
-66% -$70.4K ﹤0.01% 2980
2025
Q4 		$83.4K Buy
61,773
+61,738
+176,394% +$87.9K ﹤0.01% 2065
2025
Q3 		$57 Sell
35
-72,741
-100% -$80.6K ﹤0.01% 5140
2025
Q2 		$70.6K Buy
72,776
+49,177
+208% +$40.8K ﹤0.01% 2676
2025
Q1 		$16.7K Sell
23,599
-16,249
-41% -$11.2K ﹤0.01% 3148
2024
Q4 		$32.1K Buy
39,848
+30,120
+310% +$27.6K ﹤0.01% 2858
2024
Q3 		$9.65K Sell
9,728
-6,861
-41% -$9.42K ﹤0.01% 3849
2024
Q2 		$25.7K Buy
16,589
+1,917
+13% +$2.99K ﹤0.01% 3596
2024
Q1 		$24.1K Buy
14,672
+14,272
+3,568% +$12K ﹤0.01% 2834
2023
Q4 		$230 Sell
400
-4,029
-91% -$1.61K ﹤0.01% 5640
2023
Q3 		$1.77K Sell
4,429
-6,410
-59% -$3.17K ﹤0.01% 5267
2023
Q2 		$5.88K Sell
10,839
-64,596
-86% -$41.4K ﹤0.01% 4776
2023
Q1 		$64K Buy
75,435
+39,424
+109% +$43K ﹤0.01% 2282
2022
Q4 		$47K Sell
36,011
-90,454
-72% -$141K ﹤0.01% 2400
2022
Q3 		$225K Buy
126,465
+57,045
+82% +$142K ﹤0.01% 1816
2022
Q2 		$157K Buy
69,420
+20,692
+42% +$49.5K ﹤0.01% 1951
2022
Q1 		$161K Sell
48,728
-19,349
-28% -$68K ﹤0.01% 1888
2021
Q4 		$309K Buy
68,077
+10,875
+19% +$82.1K 0.01% 1459
2021
Q3 		$411K Buy
57,202
+47,860
+512% +$351K 0.01% 1141
2021
Q2 		$75K Buy
9,342
+8,008
+600% +$67.6K ﹤0.01% 2670
2021
Q1 		$9K Sell
1,334
-17,316
-93% -$115K ﹤0.01% 4430
2020
Q4 		$34K Buy
+18,650
New +$8.99K ﹤0.01% 3475
2016
Q4 		– Sell
-8
Closed -$2K – 4229
2016
Q3 		$2K Sell
8
-5
-38% -$782 ﹤0.01% 3112
2016
Q2 		$1K Sell
13
-4
-24% -$487 ﹤0.01% 4190
2016
Q1 		$2K Buy
17
+9
+113% +$1.43K ﹤0.01% 3414
2015
Q4 		$2K Buy
8
+2
+33% +$447 ﹤0.01% 3777
2015
Q3 		$1K Buy
6
+3
+100% +$1.08K ﹤0.01% 3655
2015
Q2 		$1K Buy
+3
New +$1.45K ﹤0.01% 4042

Other funds holding OCGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Tower Research Capital (TRC)'s OCGN Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Ocugen (OCGN) stake by 2.5% in Q2 2026, selling an estimated $807 and leaving 20,543 shares worth $31.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3139.

Tower Research Capital (TRC) first reported a position in OCGN in Q2 2015 and has held it in 29 quarters since. The position peaked at $411K in Q3 2021. 148 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

  • Tower Research Capital (TRC) held 20,543 shares of Ocugen worth $31.4K as of Q2 2026.
  • Tower Research Capital (TRC) sold 531 Ocugen shares in Q2 2026, an estimated $807.
  • Ocugen made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #3139 holding.
  • Tower Research Capital (TRC) first reported a position in Ocugen in Q2 2015 and has held it in 29 quarters since.
  • Tower Research Capital (TRC)'s Ocugen position peaked at $411K in Q3 2021.
  • 148 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.